Trial intelligence / Profile preview

Immune response to tetanus and diphtheria booster vaccination in young vs elderly adults

2009-011742-26Phase 4Completed

Sponsor
Institute for Biomedical Aging Research
Start
Apr 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, open-label trial of tetanus, diphtheria, pertussis and poliomyelitis vaccine in Tetanus, diphtheria, pertussis and 1 more (2 cohorts), sponsored by Institute for Biomedical Aging Research. Primary endpoint: Humoral and cellular immune response at 28 days. Started Apr 2009; status: completed.

02

Drugs

tetanus, diphtheria, pertussis and poliomyelitis vaccine
03

Conditions

Tetanusdiphtheriapertussispoliomyelitis

Beyond the preview

Go deeper on 2009-011742-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011742-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call